Nan Bing, M.D., Ph.D.
Dr. Bing serves as the Co-founder, Chairman and CEO of D2M Biotherapeutics. Driven by his 20 years of experiences and […]
D2M Team
Team members for the Exela
Dong Zhang, Ph.D.
Dr. Zhang’s is the Co-founder and Chief Scientific Officer at D2M Biotherapeutics. Trained as an immunologist, Dr. Zhang has 20
Sheng Yin, Ph.D.
Dr. Yin is Chief Technology Officer, and General Manager in China at D2M. As the CTO, he has over 15
Karl Qin, M.B.A.
Mr. Qin has over 28 years of management experience at leading biopharma companies and top medical institutions. Mr. Qin has
Tony Ho, M.D.
Dr. Tony Ho has 20-years of comprehensive R&D experience in the biotechnology and pharmaceutical industry. His most recent role was
Kai W. Wucherpfennig, M.D., Ph.D.
Dr. Kai W. Wucherpfennig is Chair of Cancer Immunology and Virology, and Director of the Center for Cancer Immunotherapy Research